BCAB Stock Analysis: Buy, Sell, or Hold?
BCAB - BioAtla, Inc. Common Stock
$3.78
0.16 (4.42%)
▲
5d:
+4.42%
30d:
+4.56%
90d:
+2123.47%
HOLD
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When BCAB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BCAB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BCAB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BCAB is currently trading at $3.78, which is considered fair relative to its 30-day fair value range of $3.44 to $3.89.
Technical Outlook: Technically, BCAB is in a strong uptrend. Immediate support is located at $3.12, while resistance sits at $4.22. The stock is showing strong short-term momentum, up 4.4% recently.
Market Sentiment: BCAB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $10.00 (+176.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BCAB is in a strong uptrend. Immediate support is located at $3.12, while resistance sits at $4.22. The stock is showing strong short-term momentum, up 4.4% recently.
Market Sentiment: BCAB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $10.00 (+176.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.44 -
$3.89
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
55.3%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.4%)
- BULLISH: Trading 176.2% below Wall St target ($10.00)
Trading Range Analysis
30-Day Trading Range
$3.44 -
$3.89
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.12
Resistance Level
$4.22
Current Trend
Strong Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.71
Wall Street Target
$10.00
(+176.2%)
Revenue Growth (YoY)
31.6%
Share & Embed Analysis
Last updated: June 23, 2026 11:59 AM ET
Data refreshes hourly during market hours. Next update: 12:59 PM
Data refreshes hourly during market hours. Next update: 12:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BCAB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 67 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$105 | 66 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 66 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 59 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 67 BUY |
